Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium.
about
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group ReportThe Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host DiseaseAssessment of joint and fascia manifestations in chronic graft-versus-host disease.Current issues in chronic graft-versus-host disease.Graft-versus-host disease: state of the science.FFS: an end(point) to our problems in chronic GVHD trials?Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host diseaseHow we treat chronic graft-versus-host disease.National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.Failure-free survival in a prospective cohort of patients with chronic graft-versus-host disease.Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host DiseasePredictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease.A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation.Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group reporNational Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis.Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease.Confounding factors affecting the National Institutes of Health (NIH) chronic Graft-Versus-Host Disease Organ-Specific Score and global severity.Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: a concept elicitation study.B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.Uptake and use of recommendations for the diagnosis, severity scoring and management of chronic GVHD: an international survey of the EBMT-NCI Chronic GVHD Task Force.Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHD.Grading criteria for chronic ocular graft-versus-host disease: comparing the NIH eye score, Japanese dry eye score, and DEWS 2007 score.Cancer immunotherapies, their safety and toxicity.Evolving concepts in prognostic scoring of chronic GvHD.Classification systems for chronic graft-versus-host disease.Chronic graft-versus-host disease: biological insights from preclinical and clinical studies.NIH response criteria measures are associated with important parameters of disease severity in patients with chronic GVHD.Ex Vivo CD34+-Selected T Cell-Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host DiCancer Immunotherapy, Part 2: Efficacy, Safety, and Other Clinical Considerations.Translation, Cross-Cultural Adaptation, and Validation of the Lee Chronic Graft-versus-Host Disease Symptom Scale in a Brazilian Population.Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients.Graft-versus-host disease: A rare complication of device implantation.Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host disease after allogeneic stem cell transplantation.Effect of Rituximab on Pulmonary Function in Bronchiolitis Obliterans Syndrome due to Graft-Versus-Host-Disease.The proteome pattern cGvHD_MS14 allows early and accurate prediction of chronic GvHD after allogeneic stem cell transplantation.The role of allogeneic hematopoietic stem cell transplantation in the four P medicine era.
P2860
Q26827651-B51E9CE4-BD8B-4889-9B60-4413A9EC0963Q28076264-E2760E43-D6DD-481A-B1CA-A887AFDC40D9Q33583436-C43E997B-5EF3-4A65-BDDF-78C40115D6B6Q33917187-6DA7C230-03CD-492D-86FB-FA515F7D6CB0Q33977923-B105F16A-5FC4-42E8-8478-34C6468BF330Q34077766-990C0120-4595-4A4D-8C77-7153BE128371Q34272547-47000FF2-94E8-4B15-BB09-75F8F02E59CEQ35004923-7C88F8E2-4938-4EB9-A056-72199EF1B6AFQ35085226-5A6E7230-B96F-4466-A629-63E0B0DABC3EQ35571058-87DCB255-8672-4309-A7B9-1E2FF924F17CQ36285222-42CDCBB8-FB73-4249-BBC0-2430F95E3D7DQ36443116-DD89729E-6161-4429-AC95-215A92E8C389Q36471247-F43FEE45-AE45-42BF-8AED-8D40A39EA5F2Q36554724-D0A6D618-56B8-4A5F-8299-1829239DA2C7Q36747224-70F343CB-0F85-4C82-88F8-51478E083767Q37076418-EA92784F-FB14-4642-97BF-2294C8977150Q37313795-C2BD94A5-022C-4319-B0A2-123D2F4E3FEFQ37524846-004E4C68-55F0-4DD8-9673-0B6E072F9293Q37587724-B2C7C967-FA07-48C6-BC1B-27BADCD3C58FQ37626094-CCCCAF85-749C-47FC-9C1A-639E2CFF3FFFQ37684622-7D855C6E-EF81-42AE-B96D-CE5C2161D078Q37738181-933ABB73-32A6-4478-9314-FD29937855F2Q38106230-5BE55BC5-C27D-4758-955C-B5B6A0018464Q38739174-79B545D9-6FC1-4652-A419-A735E121962DQ39002161-8300C8DE-89B8-4394-A072-60E0E60FAF51Q39002164-87BBD4E9-8A36-4198-BEAC-D512436316AFQ39140290-82FC1414-12AD-413B-A72F-1A9E536F16BDQ40407930-4CA04BB8-72B2-455A-91A5-D91EF0BE1B1CQ41064873-E90AE5AB-1A4E-4AE9-BDF1-30210D38AF18Q41529149-0CEE91A0-CE9E-4DB9-893B-C8E05E45CC08Q41932903-82AA3779-3C3F-4CF0-82B2-82BFF9423F7DQ42085196-0860DCF7-DDF5-486D-8B50-023C993828A8Q48031735-4E145168-E2FE-4706-89D9-D94680484D5EQ50143234-9FDFC51B-D840-4F6A-9E85-4C5C2FFDB900Q51455474-9B6A4E99-1E1F-4B00-BD6A-482409B67B19Q55307713-EB7F8D56-ADA5-4455-89FA-1AC5AF3546AD
P2860
Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Correlation between NIH compos ...... m the Chronic GVHD Consortium.
@ast
Correlation between NIH compos ...... m the Chronic GVHD Consortium.
@en
type
label
Correlation between NIH compos ...... m the Chronic GVHD Consortium.
@ast
Correlation between NIH compos ...... m the Chronic GVHD Consortium.
@en
prefLabel
Correlation between NIH compos ...... m the Chronic GVHD Consortium.
@ast
Correlation between NIH compos ...... m the Chronic GVHD Consortium.
@en
P2093
P2860
P1433
P1476
Correlation between NIH compos ...... om the Chronic GVHD Consortium
@en
P2093
Corey Cutler
Daniel Weisdorf
David A Jacobsohn
Georgia Vogelsang
Jeanne M Palmer
Joseph Pidala
Madan Jagasia
Mary E D Flowers
Mukta Arora
Paul J Martin
P2860
P304
2545-52; quiz 2774
P356
10.1182/BLOOD-2012-04-424135
P407
P50
P577
2012-07-06T00:00:00Z